Clinical trial
Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of…
NCT00037622 · Alexion Pharmaceuticals, Inc., Industry · Terminated
Key facts
| NCT number | NCT00037622 |
|---|---|
| Title | Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With Chronic Hepatitis B Infection. |
| Official title | An Open-Label Treatment Protocol to Provide Continued ACH-126,443 to Subjects of Previous Achillion-Sponsored Phase 1 and 2 Studies in Chronic Hepatitis B Infection |
| Lead sponsor | Alexion Pharmaceuticals, Inc., Industry |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Chronic Hepatitis B |
| Intervention type | Drug |
| Interventions | ACH-126, 443 (beta-L-Fd4C) |
| Enrollment | 100 |
| Completion | May 1, 2003 |
| First posted | May 20, 2002 |
| Last update posted | Aug 19, 2009 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: